Julie Collins

826 total citations
21 papers, 578 citations indexed

About

Julie Collins is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Julie Collins has authored 21 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Julie Collins's work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (5 papers). Julie Collins is often cited by papers focused on CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (5 papers). Julie Collins collaborates with scholars based in United States, India and China. Julie Collins's co-authors include James L. Gulley, Margaret E. Gatti‐Mays, Marijo Bilušić, Jason M. Redman, Claudia Palena, Ravi A. Madan, Renee N. Donahue, Jeffrey Schlom, Christopher R. Heery and Julius Strauss and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Julie Collins

21 papers receiving 566 citations

Peers

Julie Collins
Ying Cheng China
Yibing Peng United States
Akihiro Katayama Japan
Gino Coletti Italy
Thierry van den Bosch Netherlands
Tomomitsu Doi Japan
Thomas Packard United States
James Strauss United States
María Jesús Citores Spain
Peter Möller Germany
Ying Cheng China
Julie Collins
Citations per year, relative to Julie Collins Julie Collins (= 1×) peers Ying Cheng

Countries citing papers authored by Julie Collins

Since Specialization
Citations

This map shows the geographic impact of Julie Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Collins more than expected).

Fields of papers citing papers by Julie Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Collins. The network helps show where Julie Collins may publish in the future.

Co-authorship network of co-authors of Julie Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Collins. A scholar is included among the top collaborators of Julie Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Collins. Julie Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynce, Filipa, Xue Geng, Edward T. Richardson, et al.. (2023). 885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab. SHILAP Revista de lepidopterología. A986–A986. 1 indexed citations
2.
3.
4.
Lynce, Filipa, Xue Geng, Edward T. Richardson, et al.. (2023). Abstract CT142: TALAVE: Induction talazoparib (tala) followed by combined tala and avelumab in patients (pts) with advanced breast cancer (ABC). Cancer Research. 83(8_Supplement). CT142–CT142. 2 indexed citations
5.
Collins, Julie & Claudine Isaacs. (2020). Management of breast cancer risk inBRCA1/2mutation carriers who are unaffected with cancer. The Breast Journal. 26(8). 1520–1527. 14 indexed citations
6.
Collins, Julie, Renee N. Donahue, Claudia Palena, et al.. (2019). Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors. The Oncologist. 25(7). 560–e1006. 19 indexed citations
7.
Bilušić, Marijo, Christopher R. Heery, Julie Collins, et al.. (2019). Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. Journal for ImmunoTherapy of Cancer. 7(1). 240–240. 191 indexed citations
8.
Collins, Julie & James L. Gulley. (2018). Product review: avelumab, an anti-PD-L1 antibody. Human Vaccines & Immunotherapeutics. 15(4). 891–908. 56 indexed citations
9.
Collins, Julie, Christopher R. Heery, Renee N. Donahue, et al.. (2018). Phase I trial of BMS-986253, an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 3091–3091. 10 indexed citations
10.
Collins, Julie, Jason M. Redman, & James L. Gulley. (2018). Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy. Expert Review of Vaccines. 17(8). 697–705. 47 indexed citations
11.
Gatti‐Mays, Margaret E., Jason M. Redman, Julie Collins, & Marijo Bilušić. (2017). Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations. Human Vaccines & Immunotherapeutics. 13(11). 2561–2574. 80 indexed citations
12.
Coyne, Geraldine O’Sullivan, Shivaani Kummar, Robert Meehan, et al.. (2016). Phase I trial of oral 5-fluoro-2′-deoxycytidine with oral tetrahydrouridine in patients with advanced solid tumors. European Journal of Cancer. 69. S90–S90. 3 indexed citations
13.
Collins, Julie, Kevin Haynes, & Jason C Gallagher. (2013). Emergent Renal Dysfunction with Colistin Pharmacotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(8). 812–816. 26 indexed citations
14.
Bahl, Gautam, Irene Cruite, Tanya Wolfson, et al.. (2012). Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast‐enhanced magnetic resonance images. Journal of Magnetic Resonance Imaging. 36(5). 1154–1161. 48 indexed citations
15.
Clauss, Heather, Julie Collins, Nina Gentile, et al.. (2011). Prevalence and Characteristics of Patients with Undiagnosed HIV Infection in an Urban Emergency Department. AIDS Patient Care and STDs. 25(4). 207–211. 10 indexed citations
16.
Yokoo, Takeshi, Julie Collins, Robert F. Hanna, et al.. (2008). Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed‐phase and in‐phase imaging. Journal of Magnetic Resonance Imaging. 28(1). 246–251. 20 indexed citations
17.
Kepes, John J. & Julie Collins. (1999). Choroid Plexus Epithelium (Normal and Neoplastic) Expresses Synaptophysin. A Potentially Useful Aid in Differentiating Carcinoma of the Choroid Plexus from Metastatic Papillary Carcinomas. Journal of Neuropathology & Experimental Neurology. 58(4). 398–401. 20 indexed citations
18.
Tawfik, Ossama, et al.. (1996). Immunohistochemical Characterization of Leukocytic Subpopulations in Chronic Endometritis. Infectious Diseases in Obstetrics and Gynecology. 4(5). 287–293. 3 indexed citations
19.
Tawfik, Ossama, et al.. (1996). Immunohistochemical characterization of leukocytic subpopulations in chronic endometritis. Infectious Diseases in Obstetrics and Gynecology. 4(5). 287–293. 2 indexed citations
20.
Tawfik, Ossama, et al.. (1994). Leiomyosarcoma of the Vulva: Report of a Case. Gynecologic Oncology. 54(2). 242–249. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Yibing Peng Breakdown of academic impact, for papers by Akihiro Katayama Breakdown of academic impact, for papers by Gino Coletti Breakdown of academic impact, for papers by Thierry van den Bosch Breakdown of academic impact, for papers by Tomomitsu Doi Breakdown of academic impact, for papers by Thomas Packard Breakdown of academic impact, for papers by James Strauss Breakdown of academic impact, for papers by María Jesús Citores Breakdown of academic impact, for papers by Peter Möller
Rankless by CCL
2026